Featured

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

Roche is the biggest R&D spender investing 23.8% of its total sales

Last year, the research and development expenditures have been increased by 11% to $86.3 billion by the 11 top pharmaceutical companies of the world.

Bristol-Myers Squibb and Agenus enter a $1.56bn definitive agreement to support cancer programme

An exclusive international license contract of $1.56 billion has been signed between BMS (Bristol Myers Squibb) and Agenus, for AGEN1777

Sanofi accused of widespread employee email deletion tied to its 2019 recall of Zantac

Following FDA investigations on a contaminant suspected of causing cancer, Zantac, a renowned medication for acid reflux

Most life sciences executives say digital delivery of drugs is the future of health

The world’s leading connectivity and provider of electronic solutions, Molex and, its medical device distribution subsidiary, Phillips-Mediaize,

J&J, Allergan, Teva and Endo set to face a virtual trial over Opioid allegations

Until Covid-19, daily news focused on the involvement of pharmaceutical companies in the opioid drug addiction crisis,

Infrastructure bill, drug price controls and the impact on the pharma industry

Should the infrastructure bill be enacted, with "Aspects of H.R. 3" that include measures which peg U.S. prices of a number of prescription

Latest news

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty...
- Advertisement -

Several drug recalls hit the US market, including Pfizer’s Accupril

Leading pharmaceutical companies have been hit by recalls recently. These U.S. based drugs  include Jubilant’s Methylprednisolone ,...

Why Focus on Treating Diseases Instead of Curing Them?

It’s a tragic irony: So much money has been poured into treating diseases, but far less into...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

NeuroRX and TFF Pharmaceuticals Announce Feasibility Collaboration

Under the Feasibility Agreement, NeuroRx is delivering ZYESAMI™ materials to TFF to perform feasibility formulation work and testing.

Pfizer’s RSV vaccine given breakthrough therapy status by FDA

Pfizer’s RSVpreF is for the prevention of...

Ascendis gets FDA nod on once a week pediatric growth hormone deficiency injection

Ascendis Pharma Lonapegsomatropin-tcgd injection, Skytrofa, which is...